Back to AQR Capital Management LLC AQR Capital Management LLC

VKTX

Showing 8 of 20 quarters

Position history for AQR Capital Management LLCAQR Capital Management LLC's holdings in Viking Therapeutics, Inc.

Yes. AQR Capital Management holds 200,958 shares of VKTX (Viking Therapeutics), worth $7.8M, as of its Q2 2026 13F filing. It increased the position from 12,172 shares in Q1 2026. AQR Capital Management has held VKTX since Q1 2026, across 2 quarterly 13F filings.

Current Value

$7.8M

Current Shares

200,958

Total Value Change

-$21.3M

Total Shares Change

-262,571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
200,958
+1551.0%
$7.8M0.0%$39.01
44
2026-Q1
New
12,172
-
$390,0000.0%$32.54
33
2025-Q4
Exited
0
-100.0%
$00.0%$35.18
0
2025-Q3
Decreased
13,072
-79.8%
$334,3860.0%$26.28
0
2025-Q2
Decreased
64,728
-55.4%
$1.7M0.0%$26.50
0
2025-Q1
Decreased
145,119
-73.0%
$3.4M0.0%$24.15
0
2024-Q4
Increased
537,239
+15.9%
$21.5M0.0%$40.24
33
2024-Q3
Increased
463,529
+581.0%
$29.1M0.0%$63.31
46

Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used